Dr Marie-Claude Morice studied at the University of Medicine in Paris where she obtained her medical degree in 1973 and her Diploma in Specialized Cardiology Studies in 1975.
In 1986, she was appointed Head of the Interventional Cardiology Department of the CCN, the 2nd largest PCI center in France in 1990.
Since 1995, she has been the Head of Interventional Cardiology at the Institut Cardiovasculaire Paris (Générale de Santé) the highest-volume PCI centers in the Greater Paris Area.
Dr Morice is a Fellow of the European Society of Cardiology and the American College of Cardiology and Honorary Professor of the Universidad Del Salvador in Buenos Aires.
She is regularly invited as a guest lecturer and chairperson at all major international Cardiology scientific sessions of the AHA, ACC and ESC as well as guest faculty and live case operator in all prominent Interventional Cardiology courses (TCT, TCTAP, TOPIC, CIT, SUMMIT, EuroPCR) in Europe, North and South America and Asia and a board member and Senior Consulting Adviser of EuroPCR. She is a co-editor for EuroIntervention and an invited reviewer for the Lancet, the NEJM, JAMA, Circulation, JACC, EHJ and others.
Dr Morice has been involved in multiple clinical research activities over the past 20 years resulting in more than 250 peer-reviewed publications. She was voted Best Clinical Researcher in 1995 (Erasmus) and Cardiologist of the year in 1997.
She was the co-founder of the French study group ‘Coronary Stenting Without Coumadin’, the Principal Investigator of the Ravel Trial, the Reality Study and the co PI of the Syntax Trial in charge of the Left Main publications.
She is the President and Medical Director of the European Center for Cardiovascular Research (CERC) which was founded in 2008. CERC is now a reputable CRO conducting breakthrough CV trials worldwide. Dr. Morice has been a member of the Scientific Advisory Council of the Coeur & Recherche Foundation since 2018.
In 2013, Dr Morice was designated Best Interventional Cardiologist in France by the French magazine Capital, and in 2014 she received the CHIEN award during ASIA PCR and the Geoffrey O. Hartzler Master Operator Award at TCT 2014 for her career achievements.
Dr. Morice is a member of the executive committee of the Leaders Free, Compare Absorb, Senior and Ability DM global trials. She has been a member of the Tokyo Valve Board of Directors since 2016, and of the PCR Clinical Research Course Board of Directors since 2015.
She gave the Gruntzig Lecture during the 2017 Scientific Sessions of the ESC.
Dr. Morice is part of the ARC initiative and co-organizer of the ARC HBR initiative.
Declaration of interest
| Function | Company |
|---|---|
| None |
Latest contributions
Academic Research Consortium on LAA closure
21 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.
DES and bioadaptator technologies in contemporary practice
21 May 2025 – From EuroPCR 2025
Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
Sirolimus-coated balloon: expanding the scope of indications for complex coronary artery disease treatment
14 May 2024 – From EuroPCR 2024
Watch this session to gain case-based insights on using DCBs in complex settings. Learn valuable tips and tricks for optimal DCB application, including the best timing and situations for their use. Discover how to effectively implement a hybrid strategy that combines DES and DCB when needed.
Managing antiplatelet/antithrombotic use for high-bleeding risk patients
17 May 2023 – From EuroPCR 2023
Marie-Claude Morice and Davide Capodanno meet to discuss antiplatelet treatment in HBR patients.
In the past, a short DAPT with regular regimen was recommended for these patients, but it is now much more elaborated, as a standardized nomenclature has been established, proposing 3 types of escalation for...
Managing high-bleeding risk in case examples
18 May 2023 – From EuroPCR 2023
In these slides, discover techniques to assess bleeding and thrombotic risk in PCI patients, explore antithrombotic options, and implement strategies for risk minimisation.
EuroPCR 2023 Hotlines/Late-Breaking Trials: TAVI, hypertension, stroke prevention
17 May 2023 – From EuroPCR 2023
Want to find out what's happened lately in the field of hypertension and stroke prevention with TAVI? Check out this session where speakers give their take on what's essential to remember from a selection of studies: Primary outcome of the AnchorMan LAAO device randomised controlled trial...
Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform
16 May 2023 – From EuroPCR 2023
What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...
How should I treat a patient with LM disease: lessons from the EBC Main trial
25 Jan 2022
Watch the replay of this PCR Webinar with G. Stankovic, D. Hildick-Smith, M-C. Morice and A. Neylon.
How should I treat a patient with LM disease: lessons from the EBC Main trial
25 Jan 2022
Watch the replay of this PCR Webinar with G. Stankovic, D. Hildick-Smith, M-C. Morice and A. Neylon.
Catalysing a more equitable workforce in medicine – Women as One - EuroPCR 2022
19 May 2022
Founded in 2019 by Marie-Claude Morice and Roxana Mehran, the mission of Women as One is to promote talent in medicine by providing unique professional opportunities to women physicians.
Author
Author
Dissection and coronary perforation: how to treat
19 May 2022 – From EuroPCR 2022
Implantation of two covered stents failed to seal a perforation, coronary dissection with diagnostic catheter, jailed wire in more than one bifurcation... Take advantage of a selection of clinical cases on dissection and coronary perforation to think about how to best treat the most challenging situations!
Prevention and treatment of complications related to valve interventions
19 May 2022 – From EuroPCR 2022
To learn more about the prevention and treatment of complications related to valve interventions, watch these cases, including the case of a 70 year old with Iatrogenic aortic stenosis, the closure of paravalvular leaks of a 68 year old male affected by chronic aortic dissection or...
What's next in DES technology? Innovative DES platforms combining DES with DCB
19 May 2022 – From EUROPCR 2022
Via a series of case presentations, learn more about the dual drug delivery from DES and DCB platform to treat diabetes mellitus patients. Understand its efficiency in a complex setting and see how a no-polymer DES and DCB platform can fill the gaps of the unmet...
Daily news
18 May 2022 – From EuroPCR 2022
Treatment dilemma: when is the 2nd stent needed in bifurcation PCI?
18 May 2022 – From EuroPCR 2022
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
Treatment dilemma: the failure of provisional strategy
17 May 2022 – From EuroPCR 2022
#5 - How should I treat a patient with LM disease: lessons from the EBC Main trial
07 Oct 2021
Watch the replay of this PCR Webinar with G. Stankovic, D. Hildick-Smith, M-C. Morice and A. Neylon.
Bi-directional approach in a complex CTO - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss how to plan and guide a CTO PCI, to learn how to select the most appropriate wires and microcatheters and to appraise how to apply antegrade and retrograde techniques in a structured manner.
This session was originally presented during...
EuroPCR 2021 Andreas Grüntzig Ethica Award
20 May 2021 – From EuroPCR 2021
Relive the Ceremony during which the inspirational Dr. Marie-Claude Morice receives the 2021 Andreas Grüntzig Ethica Award, in recognition of her outstanding ongoing contribution to training, education and clinical research in interventional cardiovascular medicine.
This session was originally presented during EuroPCR 2021.
Dr. Marie-Claude Morice
One-year results from the FUTURE-II trial
19 May 2021 – From EuroPCR 2021
This LBT session, which was originally presented during EuroPCR 2021, deals with the FUTURE-II study on the new generation of bioresorbable scaffolds, providing comparative safety and efficacy evidence of the thinner-strut PLLA-based BRS in the treatment of patients with noncomplex coronary lesions.
Left Main and bifurcation PCI - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to adapt your treatment strategy to the underlying anatomy, to learn the steps of provisional left main PCI and to discuss the pitfalls of provisional left main PCI.
This session was originally presented during EuroPCR 2021.
Abluminus DES+: an innovative solution going global to beat diabetes
18 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...
2021 Ethica Award: Dr. Marie-Claude Morice to receive the 2021 Andreas Grüntzig Ethica Award
17 May 2021
Paris, France, 10 May 2021 - EuroPCR, taking place online from 18 to 20 May 2021, will be an opportunity for the interventional cardiovascular community to come together and benefit from interactive training with their peers. At this year’s web-based event, Dr. Marie-Claude Morice will be presented with the Andreas...
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
"When you think too much about the obstacles, you do little" - An interview with Marie-Claude Morice
04 Mar 2021
Dr Morice, from France, explains to PCRonline why she is convinced that women have a place in the field of medicine.
Complications in everyday PCI
13 Dec 2020 – From AICT-AsiaPCR 2020
Watch a series of clinical cases which will guide you through the process of assessing the risk of most common complications in everyday PCI, followed by tools and techniques for managing these complications.
This session was originally presented during AICT-AsiaPCR 2020.
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
